[1]
Cavallaro, G. 2024. Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy. Mediterranean Journal of Hematology and Infectious Diseases. 16, 1 (Apr. 2024), e2024049. DOI:https://doi.org/10.4084/MJHID.2024.049.